CARA O'REILLY: Open Payments
NPI 1770145120 · MIDDLETOWN, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $104 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Lilly USA, LLC | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Abbott Laboratories | 1 | $33 |
| Phathom Pharmaceuticals, Inc. | 2 | $31 |
| Astellas Pharma US Inc | 2 | $30 |
| PFIZER INC. | 1 | $27 |
| Exact Sciences Corporation | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: JARDIANCE, Wegovy, Ozempic, CAPVAXIVE, NAVITOR, VOQUEZNA, Veozah, PREVNAR 20.
Industry payments across DE — which companies pay providers there.
